Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Improving the regulatory review of drugs and devices - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 256627
Later capture
Improving the regulatory review of drugs and devices - Canada.ca
Jan 1, 2026
hc-20260101
ID 404446
updated2 sections changed
2 sections changed0 added0 removed+0 / -3 linesChange ratio: 1%
--- +++ @@ -1,6 +1,4 @@ Improving the regulatory review of drugs and devices-From:-Health Canada Health Canada is collaborating with our international partners on issues related to drug and medical device clinical trials, authorizations, risk assessments, and potential shortages. Learn about how we are engaging our international partners on COVID-19 health products issues .@@ -136,5 +134,4 @@ Information and privacy notice Transparency of stakeholder communications for the regulatory review of drugs and devices Page details-Date modified: 2025-02-28